Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients

Bernard Cosyns; Sonia Velez-Roa; Steven Droogmans; Luc A Pierard; Patrizio Lancellotti

doi:10.1016/j.ijcard.2008.06.064

Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients

Int J Cardiol. 2010 Feb 4;138(3):306-7. doi: 10.1016/j.ijcard.2008.06.064. Epub 2008 Aug 28.

Authors

Bernard Cosyns, Sonia Velez-Roa, Steven Droogmans, Luc A Pierard, Patrizio Lancellotti

PMID: 18760492
DOI: 10.1016/j.ijcard.2008.06.064

Abstract

The effects of erythropoietin administration on mitral regurgitation in patients with congestive heart failure have not yet been examined. After 2 months, erythropoietin treatment results in a significant reduction in left ventricular volumes and mitral regurgitation severity and improves hemodynamics.

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Erythropoietin / administration & dosage*
Heart Failure / drug therapy*
Humans
Mitral Valve Insufficiency / drug therapy*
Prospective Studies
Therapeutics
Ventricular Function, Left / drug effects*
Ventricular Remodeling*

Substances

Erythropoietin